FI98886B - Menetelmä antasidivalmisteiden valmistamiseksi, joilla on pidennetty viipymisaika mahalaukussa - Google Patents

Menetelmä antasidivalmisteiden valmistamiseksi, joilla on pidennetty viipymisaika mahalaukussa

Info

Publication number
FI98886B
FI98886B FI891896A FI891896A FI98886B FI 98886 B FI98886 B FI 98886B FI 891896 A FI891896 A FI 891896A FI 891896 A FI891896 A FI 891896A FI 98886 B FI98886 B FI 98886B
Authority
FI
Finland
Prior art keywords
residence time
stomach
extended residence
antacid preparations
making
Prior art date
Application number
FI891896A
Other languages
English (en)
Swedish (sv)
Other versions
FI98886C (fi
FI891896A (fi
FI891896A0 (fi
Inventor
Robert Geoffrey Willi Spickett
Vidal Jose Luis Fabregas
Escoi Juan Cucala
Original Assignee
Walton Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Walton Sa filed Critical Walton Sa
Publication of FI891896A0 publication Critical patent/FI891896A0/fi
Publication of FI891896A publication Critical patent/FI891896A/fi
Application granted granted Critical
Publication of FI98886B publication Critical patent/FI98886B/fi
Publication of FI98886C publication Critical patent/FI98886C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI891896A 1988-04-21 1989-04-20 Menetelmä antasidivalmisteiden valmistamiseksi, joilla on pidennetty viipymisaika mahalaukussa FI98886C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888809421A GB8809421D0 (en) 1988-04-21 1988-04-21 Antacid compositions with prolonged gastric residence time
GB8809421 1988-04-21

Publications (4)

Publication Number Publication Date
FI891896A0 FI891896A0 (fi) 1989-04-20
FI891896A FI891896A (fi) 1989-10-22
FI98886B true FI98886B (fi) 1997-05-30
FI98886C FI98886C (fi) 1997-09-10

Family

ID=10635574

Family Applications (1)

Application Number Title Priority Date Filing Date
FI891896A FI98886C (fi) 1988-04-21 1989-04-20 Menetelmä antasidivalmisteiden valmistamiseksi, joilla on pidennetty viipymisaika mahalaukussa

Country Status (19)

Country Link
US (1) US5288506A (fi)
EP (1) EP0338861B1 (fi)
JP (1) JPH0764724B2 (fi)
KR (1) KR950007205B1 (fi)
AT (1) ATE84708T1 (fi)
AU (1) AU616257B2 (fi)
CA (1) CA1336495C (fi)
DE (1) DE68904459T2 (fi)
DK (1) DK188489A (fi)
ES (1) ES2044099T3 (fi)
FI (1) FI98886C (fi)
GB (1) GB8809421D0 (fi)
GR (1) GR3006908T3 (fi)
HU (1) HU211236A9 (fi)
IE (1) IE61866B1 (fi)
NO (1) NO176868C (fi)
NZ (1) NZ228836A (fi)
PT (1) PT90328B (fi)
ZA (1) ZA892920B (fi)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK121193A3 (en) * 1991-04-04 1994-07-06 Procter & Gamble Chewable antacid compositions
FR2677546B1 (fr) * 1991-06-12 1994-01-21 Fabienne Joanny Composition therapeutique pour liberation prolonge de magnesium.
GB9310412D0 (en) * 1993-05-20 1993-07-07 Danbiosyst Uk Nasal nicotine system
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
DE4415999A1 (de) * 1994-05-06 1995-11-09 Bolder Arzneimittel Gmbh Magensäurebindende Kaupastillen
JP2683454B2 (ja) * 1994-06-06 1997-11-26 山之内製薬株式会社 固形制酸剤及びその製造法
US6306828B1 (en) * 1995-04-06 2001-10-23 Baxter International, Inc. Enantiomerically-enhanced nutritional energy substrates
EP0867191A4 (en) * 1995-11-27 2000-01-05 Yamanouchi Pharma Co Ltd MEDICINE COMPOSITION
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
SE9600071D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
FR2793688B1 (fr) * 1999-05-21 2003-06-13 Ethypharm Lab Prod Ethiques Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
ATE297433T1 (de) 1999-07-22 2005-06-15 Warner Lambert Co Filmbildende zusammensetzungen aus pullulan
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
EP1245227A1 (en) * 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
SE0101379D0 (sv) 2001-04-18 2001-04-18 Diabact Ab Komposition som hämmar utsöndring av magsyra
US20040006111A1 (en) * 2002-01-25 2004-01-08 Kenneth Widder Transmucosal delivery of proton pump inhibitors
SE0203065D0 (sv) 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
EP1603537A4 (en) * 2003-02-20 2009-11-04 Santarus Inc IMMEDIATE RELEASE OF OMEPRAZOLE ANTACIDAL COMPLEX WITH NEW FORMULATION FOR RAPID AND PROLONGED ELIMINATION OF GASTRIC ACID
TWI337877B (en) * 2003-07-18 2011-03-01 Santarus Inc Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
EP1648416A4 (en) * 2003-07-18 2012-03-28 Santarus Inc PHARMACEUTICAL FORMULATIONS FOR INHIBITING THE ACIDIC ACIDIFICATION AND MANUFACTURING AND USE METHOD
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
JP2006131581A (ja) * 2004-11-09 2006-05-25 Kyowa Chem Ind Co Ltd 崩壊剤及びこれを含有する崩壊性成形物
EP2026768B1 (en) * 2006-06-01 2018-02-28 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
SI2719376T1 (sl) 2012-10-12 2015-06-30 Omya International Ag Gastrointestinalna zdravilna formulacija in razdeljevalni sistem in njen naäśin priprave z uporabo funkcionaliziranega kalcijevega karbonata
EP3034070A1 (en) 2014-12-18 2016-06-22 Omya International AG Method for the production of a pharmaceutical delivery system
EP3069713A1 (en) 2015-03-20 2016-09-21 Omya International AG Dispersible dosage form
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
CA2898600A1 (en) 2015-07-28 2017-01-28 Jayson King Stuffing box containment apparatus
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
EP3269361A1 (en) 2016-07-14 2018-01-17 Omya International AG Dosage form
CN110327370B (zh) * 2019-04-16 2021-02-23 马德君 阴离子黏土用于制备驱铅药物的用途
CN110780063A (zh) * 2019-12-10 2020-02-11 无锡市尚沃医疗电子股份有限公司 一种呼气氨检测方法和装置

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1416304A (fr) * 1961-10-10 1965-11-05 Smith Kline French Lab Perfectionnements apportés aux tablettes et comprimés renfermant une importante quantité d'ingrédient actif libéré pendant un laps de temps prolongé, et aux procédés pour leur préparation
CA948107A (en) * 1970-04-28 1974-05-28 Robert S. Joslin Coated antacid compositions of improved taste
US4101650A (en) * 1977-04-06 1978-07-18 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Pepstatin floating minicapsules
HU179474B (en) * 1978-02-24 1982-10-28 Laszlo Gyarmati Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material
MTP930B (en) * 1982-04-30 1984-04-10 Delandale Labs Ltd Substained release lithium-containing tablets and method for their manufacture
US4605551A (en) * 1984-11-30 1986-08-12 William H. Rorer, Inc. Dry oil coated antacid process
US4778676A (en) * 1985-12-20 1988-10-18 Warner-Lambert Company Confectionery delivery system for actives
JPS62195323A (ja) * 1986-02-24 1987-08-28 Eisai Co Ltd 胃内滞留型粒子
WO1988000051A1 (en) * 1986-06-24 1988-01-14 Racz Istvan Proceeding for the production of pharmaceutical preparations of high gastric acid binding capacity, of retarded effect and of increased bioavailability

Also Published As

Publication number Publication date
FI98886C (fi) 1997-09-10
DK188489D0 (da) 1989-04-19
NO891641D0 (no) 1989-04-20
AU616257B2 (en) 1991-10-24
JPH0764724B2 (ja) 1995-07-12
ES2044099T3 (es) 1994-01-01
KR890015733A (ko) 1989-11-25
NO176868C (no) 1995-06-14
NZ228836A (en) 1990-09-26
DE68904459D1 (de) 1993-03-04
NO176868B (no) 1995-03-06
HU211236A9 (en) 1995-11-28
CA1336495C (en) 1995-08-01
ATE84708T1 (de) 1993-02-15
GR3006908T3 (fi) 1993-06-30
DE68904459T2 (de) 1993-05-13
KR950007205B1 (ko) 1995-07-04
FI891896A (fi) 1989-10-22
PT90328A (pt) 1989-11-10
IE61866B1 (en) 1994-11-30
US5288506A (en) 1994-02-22
AU3317589A (en) 1989-10-26
NO891641L (no) 1989-10-23
EP0338861A2 (en) 1989-10-25
DK188489A (da) 1989-10-23
ZA892920B (en) 1989-12-27
JPH0215025A (ja) 1990-01-18
FI891896A0 (fi) 1989-04-20
EP0338861A3 (en) 1990-09-19
PT90328B (pt) 1994-11-30
IE891282L (en) 1989-10-21
GB8809421D0 (en) 1988-05-25
EP0338861B1 (en) 1993-01-20

Similar Documents

Publication Publication Date Title
FI98886B (fi) Menetelmä antasidivalmisteiden valmistamiseksi, joilla on pidennetty viipymisaika mahalaukussa
NO885213D0 (no) Stabiliserte legemidler, fremgangsmŸte til deres fremstilling samt stabile legemiddeltilberedninger.
GR3005640T3 (fi)
DK0449247T3 (da) Farmaceutisk formulering indeholdende galanthamin til behandling af alkoholisme
ES2072987T3 (es) Dispositivo de retencion gastrico.
ES2041699T3 (es) Procedimiento de preparacion de un medicamento a base de fenofibrato y medicamento obtenido por este procedimiento.
SE8803141L (sv) Naeringsmedel foer maenniskor och djur
AU7264187A (en) Formulations containing unsaturated fatty acids for the synthesis of prostaglandins and hydroxy-fatty acids in biological systems
DE69001487D1 (de) Gemfibrozil enthaltende mittel mit verlaengerter freigabe.
SE8800080D0 (sv) Lekemedelskomposition
NO874850D0 (no) Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
NL7700425A (nl) Werkwijze voor de bereiding van preparaten en stoffen tegen maagzuur en maagzweren.
ES2018952A6 (es) Procedimiento de preparacion de composiciones antiacidas con tiempo prolongado de permanencia gastrica.
DE69214333D1 (de) Arzneizubereitung mit hohem Gehalt an Ibuprofenlysinat
AU4434389A (en) Aqueous oral pharmaceutical preparation of diclofenac
EP0390849A4 (en) Methyl cellulose pharmaceutical composition
ES2045366T3 (es) Procedimiento para la preparacion de l-fosfinotricina.
GB2025224B (en) Pharmaceutical compositions comprising trimethoprim and n ethyl pyridone 3 carboxylic acid derivatives
NL193184B (nl) Werkwijze voor het bereiden van azoniaspironortropanolesters en farmaceutisch preparaat dat een dergelijke ester bevat.
NO913397D0 (no) Monokarboksylsyreestere og olefinpolymer-sammensetning stabilisert dermed.
NO903994L (no) Fremgangsmaate for fremstilling av 5-aroyl-1,2-dihydro-3h-pyrrolo-(1,2-a)-pyrrol-1-carboxylsyrer og alkylestere og salter derav.
MX6987E (es) Procedimiento para la obtencion de preparados a base de paredes celulares o de celulas enteras del propionibacterium granulosum dsm 1773 propionibacterium avidum dsm 1772 y/o propionibacterium acnes atcc-6919
NL177210B (nl) Anti-arritmische n,n'-bis-(fenylcarbamoylmethyl)amidinen, werkwijze voor het bereiden daarvan en farmaceutische preparaten die deze stoffen bevatten.

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: FORDONAL S.L.

MM Patent lapsed

Owner name: FORDONAL S.L.